João Albuquerque
About João Albuquerque
João Albuquerque is a Senior Medical Science Liaison for Spain and Portugal at Insmed Incorporated, with extensive experience in sales management and market analysis in the biotechnology sector, particularly in rare diseases.
Current Role at Insmed
João Albuquerque serves as the Senior Medical Science Liaison for Spain and Portugal at Insmed Incorporated. He has held this position since 2020, contributing to the company's efforts in the biotechnology sector, particularly in the area of rare diseases. His role involves engaging with healthcare professionals and stakeholders to provide scientific support and facilitate the understanding of Insmed's products.
Previous Experience in Pharmaceuticals
Before joining Insmed, João Albuquerque accumulated extensive experience in the pharmaceutical industry. He worked at Alexion Pharmaceuticals, Inc. as a National Account Manager for Portugal from 2016 to 2019. Prior to that, he held the position of Alexion Consultant from 2009 to 2016. His career also includes a six-year tenure at Merck as an Account Manager in Oncology and a decade at AstraZeneca as a Senior Hospital Oncology Representative.
Education and Professional Background
João Albuquerque completed his high school education at D.Duarte High School, focusing on Humanistics from 1983 to 1985. He later attended Law School at the University of Coimbra, where he studied Law for nine years, although he did not complete the degree. His educational background supports his professional orientation towards sales and marketing within the biotechnology industry.
Skills in Market Analysis and Sales Management
João Albuquerque possesses strong skills in sales management and market analysis. His experience spans various therapeutic areas at the hospital level, enabling him to effectively navigate the complexities of market planning and access within the biotechnology sector. His expertise is particularly relevant in the context of rare diseases, where he leverages his knowledge to drive strategic initiatives.